Cell adhesion molecule expression in cord blood CD34+ cells

Stem Cells
F TimeusV Gabutti

Abstract

Self-renewal, proliferation, differentiation, homing, and mobilization of hematopoietic progenitor cells (HPCs) are regulated by a complex mechanism that involves the bone marrow (BM) microenvironment. Cell adhesion molecules (CAMs) expressed on HPCs and on endothelial and stromal cells play a pivotal role in this process. In this study, we have used three-color cytofluorometric analysis to compare CAM expression in the subsets of cord blood (CB) and BM HPCs and examined the effect of a short exposure to various cytokines on L-selectin expression. The study was carried out on unseparated samples to avoid any possible bias from positive CD34 selection. CAMs were highly expressed in both CB and BM CD34+CD38+ cells. In this population, L-selectin, H-CAM, and LFA-1 were significantly more expressed in BM than in CB. With regard to the more immature progenitors, the subsets of CD34+/CD38-/L-selectin+ and CD34+/CD38-/LFA1+ cells were significantly larger in CB than in BM. Since the expression of such CAMs has been related to the repopulating capacity of HPCs, our results suggest a possible advantage in homing and engraftment of more undifferentiated CB as opposed to BM HPCs. A 4/24-h exposure to various cytokines significantly increa...Continue Reading

References

Jan 1, 1979·Acta Haematologica·T M Dexter
Aug 1, 1992·The Journal of Clinical Investigation·J TeixidóP Anklesaria
Feb 1, 1990·The Journal of Experimental Medicine·K MiyakeP W Kincade
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H E BroxmeyerE A Boyse
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T Papayannopoulou, B Nakamoto
Jul 18, 1996·The New England Journal of Medicine·J KurtzbergP Rubinstein

❮ Previous
Next ❯

Citations

Jan 6, 2011·International Journal of Hematology·Shohei YamamotoKeiichi Isoyama
Jun 14, 2003·Journal of Hematotherapy & Stem Cell Research·Nicholas J GrecoGary Moroff
Jun 15, 1999·Pediatric Research·J M KoenigA B Deisseroth
Oct 16, 2015·Artificial Cells, Nanomedicine, and Biotechnology·Farzaneh MoghaddamNaser Amirizadeh
Oct 24, 2003·Allergologia et immunopathologia·F MastrandreaP G Natali
Jan 30, 2004·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Joachim OswaldCarsten Werner
Oct 13, 2007·European Journal of Cell Biology·Annika Wulf-GoldenbergIduna Fichtner
Sep 25, 2001·American Journal of Obstetrics and Gynecology·D V SurbekW Holzgreve
Nov 21, 2000·American Journal of Obstetrics and Gynecology·D V SurbekW Holzgreve
Nov 23, 2005·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·P PrankeJ Visser
Apr 28, 2019·International Journal of Molecular Sciences·Zahra MasoumiStefan R Hansson
Apr 4, 2021·International Journal of Molecular Sciences·Zahra MasoumiStefan R Hansson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.